Disparity in Life Expectancy and Biomedical Innovation

7min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter explores the disparity in life expectancy between the top 1% and the poorest 1% of Americans, questioning the purpose of our biomedical innovation system and proposing public engagement to address scientific priorities and funding decisions.

The United States is justifiably proud of the accomplishments of its taxpayer-funded biomedical innovation system. But these innovations don’t benefit all Americans equally, which means, among other things, that the richest live 10 to 15 years longer than the very poor. In this episode we speak with Shobita Parthasarathy, a professor at the University of Michigan and director of the Science, Technology, and Public Policy Program. Parthasarathy explains how to think differently about the country’s innovation system—by removing societal bias, rethinking patents, and ensuring equitable access to medical advances—to allow all Americans to thrive.

Read Shobita Parthasarathy’s article, Innovation as a Force for Equity.

Explore more of Parthasarathy’s work by visiting her website.

Check out Parthasarathy’s podcast, The Received Wisdom, a podcast about how to realize the potential of science and technology by challenging the received wisdom.

Visit issues.org for more episodes, conversations and articles. Follow us on Twitter, Facebook, and LinkedIn! Comments? Questions? Tweet us or email us at podcast@issues.org.